No Data
No Data
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Cautious Optimism Amidst Clinical Uncertainties: A Hold Rating for Marinus Pharmaceuticals
A Quick Look at Today's Ratings for Marinus Pharmaceuticals(MRNS.US), With a Forecast Between $11 to $11
Express News | HC Wainwright & Co. Reiterates Buy on Marinus Pharma, Maintains $11 Price Target
A Quick Look at Today's Ratings for Marinus Pharmaceuticals(MRNS.US), With a Forecast Between $3 to $11
Marinus Pharma Analyst Ratings
No Data